C07C 237/38
Having the nitrogen atom of the carboxamide group bound to a carbon
Official title: having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
C07C237/38 (Having the nitrogen atom of the carboxamide group bound to a carbon) appears on 84 US grants and 78 published applications in this corpus.
Search patents in C07C- Granted patents
- 84
- Published applications
- 78
- Assignees
- 54
- Inventors
- 317
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 3 | 0 |
| 2002 | 14 | 5 |
| 2003 | 3 | 13 |
| 2004 | 13 | 3 |
| 2005 | 0 | 3 |
| 2006 | 2 | 2 |
| 2007 | 3 | 4 |
| 2008 | 2 | 6 |
| 2009 | 1 | 2 |
| 2010 | 8 | 6 |
| 2011 | 2 | 1 |
| 2012 | 2 | 2 |
| 2013 | 4 | 3 |
| 2014 | 2 | 3 |
| 2015 | 4 | 2 |
| 2016 | 3 | 4 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 3 |
| 2021 | 0 | 3 |
| 2022 | 3 | 3 |
| 2023 | 2 | 2 |
| 2024 | 2 | 5 |
| 2025 | 1 | 1 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modulators of programmed death-ligand-122 Sep 2026US 12,741,965 B2Southern Research Institute
- Inhibitors of the Wnt/beta-catenin pathway2 Sep 2025US 12,404,243 B2The Regents of the University of California
- Trisamide compounds and compositions comprising the same10 Sep 2024US 12,084,400 B2Milliken & Company
- Modulators of mas-related G-protein receptor X2 and related products and methods9 Apr 2024US 11,952,346 B2Escient Pharmaceuticals, Inc.
- Trisamide compounds and compositions comprising the same3 Oct 2023US 11,773,054 B2Milliken & Company
- Novel inhibitors of dna damage responses for cancer therapy23 Jul 2026US 2026/0209193 A1The Regents of the University of California
- Rxfp1 agonists10 Jul 2025US 2025/0221966 A1Bristol-Myers Squibb Company
- Modulators of the integrated stress pathway19 Sep 2024US 2024/0307382 A1AbbVie Inc.
- Modulators of mas-related g-protein receptor x2 and related products and methods18 Jul 2024US 2024/0239749 A1Escient Pharmaceuticals, Inc.
- Inhibitors of the wnt/beta-catenin pathway22 Feb 2024US 2024/0059654 A1The Regents of the University of California
Most cited
By later US patents
- 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors87US 6,310,060 B1Warner-Lambert Company · 2001
- Acylated arylcycloalkylamines and their use as pharmaceuticals59US 7,186,735 B2Sanofi-Aventis Deutschland GmbH · 2007
- Acylated indanyl amines and their use as pharmaceuticals30US 7,179,839 B2Sanofi-Aventis Deutschland GmbH · 2007
- Amine derivative compounds for treating ophthalmic diseases and disorders28US 8,076,516 B2Acucela Inc. · 2011
- Carboxamido opioid compounds22US 7,244,866 B2Janssen Pharmaceutical N.V. · 2007